Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 5301 - 5325 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Diacylglycerophosphoinositolglycans LMGP15010193
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:2(9Z,12Z)/18:1(9Z))
126457561 1522.768433 C70H123O33P
LMSL03001267
  • 2-octadecanoyl-3-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-6-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-2'-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-4'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-alpha,alpha-trehalose
  • PAT18(24:0(2Me[R],3OH[R],4Me[S],6Me[S])/24:0(2Me[R],3OH[R],4Me[S],6Me[S])/24:0(2Me[R],3OH[R],4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S]))
52931104 2195.922235 C136H258O19
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA06
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Gb3(d18:1/26:0)
44260169 75188 1163.827069 C62H117NO18
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE08
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • SSEA-3 antigen(d18:1/26:1(17Z))
44260203 1526.943618 C76H138N2O28
LMSL03000003
  • 2-O-hexadecanoyl-3-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-alpha,alpha-trehalose
  • DAT(16:0/24:0(2Me[R],3OH[R],4Me[S],6Me[S]))
52929840 988.74261 C55H104O14
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BS06
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261329 2989.488064 C132H232N6O68
Simple Glc series LMSP05010102
  • Cerebroside E
  • N-(2R-hydroxy-octadecanoyl)-1-beta-glucosyl-9-methyl-pentadecasphing-4E,8E-dienine
127034832 713.544184 C40H75NO9
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AD02
  • Forssman-like iGb4(d18:1/18:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261861 1457.860617 C70H127N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AA00
  • Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer
Gangliosides LMSP0601AB02
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • SSEA-4 antigen(d18:1/18:0)
44261973 1707.929487 C79H141N3O36
Gangliosides LMSP0601AU08
  • GQ1c(d18:1/26:1(17Z))
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262131 2529.272469 C114H196N6O55
Rhamnolipids LMFA13030007
  • 3-O-(2-O-(2E-decenoyl)-alpha-L-rhamnopyranosyl-(1-2)-alpha-L-rhamnopyranosyl)-3-hydroxydecanoic acid
14495943 802.50786 C42H74O14
Gangliosides LMSP0601GD01
  • NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44263156 4581.924813 C188H316N12O115
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CJ01
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Lea -X(d18:1/16:0)
44261460 1883.997962 C86H153N3O41
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BE04
  • GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260407 1675.976042 C80H145N3O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AO01
  • Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260276 1185.723394 C58H107NO23
LMSL03000947
  • 2-octadecanoyl-3-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-6-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-alpha,alpha-trehalose
  • PAT18(25:1(2E)(2Me,4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S]))
52930784 2141.89054 C136H252O16
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AM05
  • Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260264 1459.901419 C72H133NO28
Simple Glc series LMSP05010091
  • GlcCer(d18:3(4E,8E,10E)(9Me)/16:0)
  • N-(hexadecanoyl)-1-alpha-glucosyl-9-methyl-4E,8E,10E-sphingatrienine
139586583 709.549269 C41H75NO8
Ascarosides LMFA13040002
  • 6R-(3,6-dideoxy-alpha-L-arabino-hexopyranosyloxy)-heptanoic acid
  • Daumone
11471380 78786 276.15729 C13H24O6
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504BM07
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260914 2562.319085 C116H203N5O56
Gangliosides LMSP0601CT07
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262522 2210.14575 C101H175N5O47
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504BU01
  • Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260964 1388.802768 C66H120N2O28
LMSL03000959
  • 2-octadecanoyl-3-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-6-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-alpha,alpha-trehalose
  • PAT18(25:1(2E)(2Me,4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S]))
52930796 2225.98444 C142H264O16
LMSL03000287
  • 2-O-hexadecanoyl-3-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-6-O-(2,4S,6S-trimethyl-2E-docosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-alpha,alpha-trehalose
  • PAT16(25:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S]))
52930124 2127.87489 C135H250O16

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024